Two of my stocks in my trading portfolio have been trading poorly. KRON warned that current quarter would come in at low end of expectations due to failure to close some contracts and ELAB has been held up with one of its generic drugs with a lawsuit. With my margin levels high, and my tolerance for problem stocks low, I sold both of these positions this morning. We actually still have nice gains on both of these...but now we are back to 23 positions...so have two more slots to fill in my trading portfolio. The 120 share position was sold at $46.52 and the 120 share position of KRON was sold at $38.10.
ELAB was purchased at $29.39 on 5/30/03 and has resulted in a 59.80% gain. KRON was acquired on 4/8/03 with a basis of $27.49 so the current sale netted a 38.87% gain. Not too shabby!
Thanks for stopping by!